XL-647
|
|
|
- CAS号:
- 781613-23-8
- 英文名:
- XL-647
- 英文别名:
- KD-019;XL-647;Tesevatinib;XL647 /EXEL-7647;Tesevatinib(XL647);EXEL-7647;XL-647;XL 647;Tesevatinib, 10 mM in DMSO;Rel-N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine;N-(3,4-dichloro-2-fluorophenyl)-6-Methoxy-7-(((3aR,6aS)-2-Methyloctahydrocyclopenta[c]pyrrol-5-yl)Methoxy)quinazolin-4-aMine;N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine
- 中文名:
- XL-647
- 中文别名:
- 抑制剂XL647;抑制剂XL647;化合物TESEVATINIB;多靶点酪氨酸激酶抑制剂(XL-647);化合物TESEVATINIB,10 MM DMSO 溶液;XL-647 (Tesevatinib;EXEL-7647;KD-019);N-(3,4-二氯-2-氟苯基)-6-甲氧基-7-(((3AR,5R,6AS)-2-甲基八氢环戊烷并[C]吡咯-5-基)甲氧基)喹唑啉-4-胺;N-(3,4-二氯-2-氟苯基)-6-甲氧基-7-(((3AR,5R,6AS)-2-甲基八氢环戊戊二烯并[C]吡咯-5-基)甲氧基)喹唑啉-4-胺;N-(3,4-二氯-2-氟苯基)-6-甲氧基-7-[[(3AALPHA,5BETA,6AALPHA)-八氢-2-甲基环戊并[C]吡咯-5-基]甲氧基]-4-喹唑啉胺
- CBNumber:
- CB82628532
- 分子式:
- C24H25Cl2FN4O2
- 分子量:
- 491.3853032
- MOL File:
- 781613-23-8.mol
|
|
|
XL-647化学性质
-
沸点:
-
567.9±50.0 °C(Predicted)
-
|
-
密度:
-
1.356
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMF: 10 mg/ml; DMSO: 10 mg/ml; Ethanol: 10 mg/ml
-
|
-
酸度系数(pKa):
-
10.16±0.40(Predicted)
-
|
-
形态:
-
A solid
-
|
-
颜色:
-
White to off-white
-
|
-
InChIKey:
-
HVXKQKFEHMGHSL-QKDCVEJENA-N
-
|
-
SMILES:
-
N(C1C=CC(Cl)=C(Cl)C=1F)C1=NC=NC2C=C(OC[C@H]3C[C@@]4([H])CN(C)C[C@@]4([H])C3)C(OC)=CC1=2 |&1:19,21,27,r|
-
|
XL-647性质、用途与生产工艺
XL-647(Tesevatinib;XL-647;KD-019)是多靶点酪氨酸激酶抑制剂;抑制EGFR，ErbB2，KDR，Flt4和EphB4激酶活性的IC50值分别为0.3，16，1.5，8.7，和1.4nM。
XL-647
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2025/05/22 | HY-13314 | Tesevatinib | 781613-23-8 | 1 mg | 1142元 |
| 2025/05/22 | HY-13314 | XL-647
Tesevatinib | 781613-23-8 | 5mg | 2700元 |
781613-23-8, XL-647 相关搜索:
- 抑制剂
- 标准品
- 细胞生物学试剂
- C24H25Cl2FN4O2
- 抑制剂XL647
- 抑制剂XL647
- XL-647 (Tesevatinib;EXEL-7647;KD-019)
- 多靶点酪氨酸激酶抑制剂(XL-647)
- 化合物TESEVATINIB,10 MM DMSO 溶液
- N-(3,4-二氯-2-氟苯基)-6-甲氧基-7-(((3AR,5R,6AS)-2-甲基八氢环戊烷并[C]吡咯-5-基)甲氧基)喹唑啉-4-胺
- 化合物TESEVATINIB
- N-(3,4-二氯-2-氟苯基)-6-甲氧基-7-(((3AR,5R,6AS)-2-甲基八氢环戊戊二烯并[C]吡咯-5-基)甲氧基)喹唑啉-4-胺
- N-(3,4-二氯-2-氟苯基)-6-甲氧基-7-[[(3AALPHA,5BETA,6AALPHA)-八氢-2-甲基环戊并[C]吡咯-5-基]甲氧基]-4-喹唑啉胺
- 781613-23-8
- Tesevatinib, 10 mM in DMSO
- N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine
- 4-Quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aα,5β,6aα)-octahydro-2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-
- XL647 /EXEL-7647
- XL647,Tesevatinib,EXEL 7647,KD019,HER1,Ephrin Receptor,Inhibitor,VEGFR,KD 019,Vascular endothelial growth factor receptor,Epidermal growth factor receptor,EGFR,ErbB-1,XL 647,EXEL7647,inhibit
- Rel-N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-2-methyloctahydrocyclopenta[c]pyrrol-5-yl)methoxy)quinazolin-4-amine
- KD-019
- EXEL-7647;XL-647;XL 647
- N-(3,4-Dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aalpha,5beta,6aalpha)-octahydro-2-methylcyclopenta[c]pyrrol-5-yl]methoxy]-4-quinazolinamine
- N-(3,4-dichloro-2-fluorophenyl)-6-Methoxy-7-(((3aR,6aS)-2-Methyloctahydrocyclopenta[c]pyrrol-5-yl)Methoxy)quinazolin-4-aMine
- XL-647
- Tesevatinib(XL647)
- Tesevatinib